First National Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
First National Advisers's AMGN Position: Q2 2026 in Review
First National Advisers reduced its Amgen (AMGN) stake by 7.7% in Q2 2026, selling an estimated $437K and leaving 15,261 shares worth $5.53M. The position accounts for 0.78% of the portfolio, ranked #26.
First National Advisers first reported a position in AMGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $6.67M in Q4 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- First National Advisers held 15,261 shares of Amgen worth $5.53M as of Q2 2026.
- First National Advisers sold 1,276 Amgen shares in Q2 2026, an estimated $437K.
- Amgen made up 0.78% of First National Advisers's portfolio in Q2 2026, its #26 holding.
- First National Advisers first reported a position in Amgen in Q3 2022 and has held it in 15 quarters since.
- First National Advisers's Amgen position peaked at $6.67M in Q4 2025.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.